Management of Hypertension in Elderly Women

Rationale for Combination Therapy

The European Society of Cardiology recommends that elderly patients frequently need combination therapy to reach target blood pressure, with approximately two-thirds of elderly hypertensive patients requiring at least two agents to achieve adequate blood pressure control 3
The American Heart Association suggests that calcium channel blockers like amlodipine are specifically proven effective in elderly populations, as most elderly patients require two or more drugs to achieve blood pressure control 1, 2

The European Society of Cardiology states that amlodipine-based therapy reduced cardiovascular events by 17% in patients ≥65 years compared to atenolol-based therapy, with absolute benefits greater in older patients due to higher baseline event rates 1, 2
The American College of Cardiology recommends that angiotensin receptor antagonists were more effective than atenolol in reducing cardiovascular events, particularly stroke, in 55-to-80-year-old hypertensive patients 1, 2

The American Heart Association suggests target systolic blood pressure <140 mmHg for elderly patients under 80 years, and 140-145 mmHg if tolerated for those ≥80 years 3
The European Society of Cardiology recommends <130/80 mmHg for most adults, individualized based on frailty 4, 3
The American College of Cardiology states that diastolic BP should be maintained >70-75 mmHg if coronary heart disease is present to prevent reduced coronary perfusion 3

The European Society of Cardiology recommends monitoring for orthostatic hypotension at each visit, as elderly patients have increased risk due to stiff arteries and decreased baroreflex buffering 1, 2, 3

The American Heart Association states that current guidelines favor ACE inhibitors or ARBs as preferred add-on agents for non-Black elderly patients 4
The European Society of Cardiology suggests that amlodipine remains an excellent evidence-based choice if there are contraindications to renin-angiotensin system blockers or if the patient has isolated systolic hypertension 1, 2

The American College of Cardiology recommends reassessing blood pressure after 4 weeks of amlodipine 2.5 mg daily 4, 3
The European Society of Cardiology states that achieving target blood pressure within 3 months is recommended 4, 3
The American Heart Association suggests considering home blood pressure monitoring (target <135/85 mmHg) or 24-hour ambulatory monitoring (target <130/80 mmHg) to confirm adequate control 4, 3